Skip to main content

LifeMD, Inc.

corporate_fare Company Profile

LifeMD, Inc.

LFMD·NASDAQ·Healthcare·CIK 0000948320

LifeMD is a patient-centric, direct-to-patient healthcare company that provides virtual medical care and pharmacy services. The company aims to offer a high-quality, cost-effective, and convenient alternative to the traditional healthcare model. LifeMD addresses shortages in U.S. primary care and key specialty areas through a vertically integrated care model. This model combines proprietary technology, affiliated clinical services, pharmacy infrastructure, and AI-enabled operational systems to deliver ongoing care at scale. As of December 31, 2025, LifeMD served approximately 328,000 active patient subscribers. The company provides virtual clinical services and prescription and over-the-counter (OTC) treatments for a range of healthcare needs, including primary care, men's and women's health, hormone health, weight management, insomnia, dermatology, and cardiology. Virtual primary care services are primarily offered through a subscription model. Since its inception, LifeMD has served approximately 1,387,000 patients and customers. Telehealth revenue increased 25% for the year ended December 31, 2025, compared to the year ended December 31, 2024. Approximately 95% of LifeMD's total revenue is derived from recurring subscriptions. The company operates a proprietary, fully integrated telehealth and pharmacy platform that supports diagnosis, treatment, prescription fulfillment, and ongoing care management within a unified ecosystem. This platform is designed to provide cohesive patient experiences for those utilizing LifeMD's affiliated pharmacy.

LifeMD, Inc. (NASDAQ:LFMD) is a publicly traded company in the Healthcare sector. Wiseek monitors LFMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • LifeMD Reports Wider Q1 Loss, Breaches Debt Covenant, Raising Liquidity Concerns
  • LifeMD Reports Mixed Q1 Results: Revenue Beats Guidance Amid Wider Net Loss and Strong Subscriber Growth
  • LifeMD Q1 Revenue Surges Past Estimates on Record Telehealth Subscriber Growth
  • LifeMD Now Offers Eli Lilly's New Oral GLP-1 Foundayo for Weight Management
  • LifeMD Appoints Veteran Healthcare Finance Executive Atul Kavthekar as New CFO; Expands Leadership Team

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$194.06M
Net Income
$14.35M
Diluted EPS
$0.25
Op. Cash Flow
$8.28M
Free Cash Flow
$6.41M
Gross Profit
$166.34M
Operating Income
-$7.67M
Cash & Equivalents
$36.79M
Debt / Equity
0.00×
Net Margin
7.4%
Shares Outstanding
46.66M sh
Source: 10-K · filed 2026-03-10 · accession 0001493152-26-009549
Browse all tickers starting with L →
$4.77 +0.07% today
52-week range · as of 2026-05-06 $2.56 – $15.84
Market cap
$227.3M
Volume
773.5K (0.8× avg)
3-mo avg 969.5K
Live data · 2026-06-14 03:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LFMD - Latest Insights

LFMD
May 06, 2026, 5:24 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.63
Real-time Price: $4.77 info
Change: +$0.140 (+3%) info
Market Cap: $227.304M info
LFMD
May 06, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.57
Real-time Price: $4.77 info
Change: +$0.1994 (+4%) info
Market Cap: $227.304M info
LFMD
May 06, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.60
Real-time Price: $4.77 info
Change: +$0.1687 (+4%) info
Market Cap: $227.304M info
LFMD
Apr 10, 2026, 8:15 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.41
Real-time Price: $4.77 info
Change: +$1.36 (+40%) info
Market Cap: $227.304M info
LFMD
Mar 18, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.08
Real-time Price: $4.77 info
Change: +$0.690 (+17%) info
Market Cap: $227.304M info
LFMD
Mar 10, 2026, 4:56 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.82
Real-time Price: $4.77 info
Change: +$0.950 (+25%) info
Market Cap: $227.304M info
LFMD
Mar 09, 2026, 4:37 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $4.77 info
Change: +$1.29 (+37%) info
Market Cap: $227.304M info
LFMD
Mar 09, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $4.77 info
Change: +$1.17 (+32%) info
Market Cap: $227.304M info
LFMD
Jan 06, 2026, 9:19 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.95
Real-time Price: $4.77 info
Change: +$0.820 (+21%) info
Market Cap: $227.304M info